发明申请
- 专利标题： COMPOUNDS AND THERAPEUTICAL USE THEREOF
- 专利标题（中）： 化合物及其治疗用途
-
申请号： US12500863申请日： 2009-07-10
-
公开(公告)号： US20100069383A1公开(公告)日： 2010-03-18
- 发明人: MARK B. ANDERSON , J. Adam Willardsen , Warren S. Weiner , Ashantai Yungai , Robert J. Halter , Yevgeniya Klimova , Kazuyuki Suzuki , Matthew Reeder
- 申请人： MARK B. ANDERSON , J. Adam Willardsen , Warren S. Weiner , Ashantai Yungai , Robert J. Halter , Yevgeniya Klimova , Kazuyuki Suzuki , Matthew Reeder
- 申请人地址： US UT Salt Lake City
- 专利权人： Myriad Pharmaceuticals, Incorporated
- 当前专利权人： Myriad Pharmaceuticals, Incorporated
- 当前专利权人地址： US UT Salt Lake City
- 主分类号： A61K31/517
- IPC分类号： A61K31/517 ; A61K31/5377 ; A61K31/52 ; C07D413/12 ; C07D473/00 ; C07D401/12 ; C07D239/95
摘要：
Disclosed are 4-arylamino-quinazolines and analogs thereof that are effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
公开/授权文献
- US08309562B2 Compounds and therapeutical use thereof 公开/授权日：2012-11-13
信息查询
IPC分类:
